AnaptysBio Inc (NASDAQ:ANAB) shares, rose in value on Wednesday, June 18, with the stock price down by -1.81% to the previous day’s close as strong demand from buyers drove the stock to $23.39.
Actively observing the price movement in the last trading, the stock closed the session at $23.82, falling within a range of $23.025 and $24.09. The value of beta (5-year monthly) was -0.266. Referring to stock’s 52-week performance, its high was $41.31, and the low was $12.21. On the whole, ANAB has fluctuated by 14.26% over the past month.
With the market capitalization of AnaptysBio Inc currently standing at about $687.21 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-05.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.68M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ANAB’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of ANAB currently trading nearly 4.44% and 12.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 57.54, while the 7-day volatility ratio is showing 1.79% which for the 30-day chart, stands at 4.55%. Furthermore, AnaptysBio Inc (ANAB)’s beta value is -0.27, and its average true range (ATR) is 1.51.
A comparison of AnaptysBio Inc (ANAB) with its peers suggests the former has fared considerably weaker in the market. ANAB showed an intraday change of -1.81% in last session, and over the past year, it shrunk by -1.60%%.
Data on historical trading for AnaptysBio Inc (NASDAQ:ANAB) indicates that the trading volumes over the past 10 days have averaged 0.68 and over the past 3 months, they’ve averaged 749.22K. According to company’s latest data on outstanding shares, there are 30.39 million shares outstanding.
Nearly 9.88% of AnaptysBio Inc’s shares belong to company insiders and institutional investors own 128.18% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.21 million shares as on 2025-05-30, resulting in a short ratio of 16.72. According to the data, the short interest in AnaptysBio Inc (ANAB) stood at 5656.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 8.96 million. The stock has risen by 76.66% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ANAB stock heading into the next quarter.
